We are live on ! Find out more
CALA

Calithera Biosciences, Inc
CALA

Delisted

CALA was delisted on the 1st of February, 2023.

Back to rankings

112 hedge funds and large institutions have $204M invested in Calithera Biosciences, Inc in 2017 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 38 increasing their positions, 23 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

140% more first-time investments, than exits

New positions opened: 36 | Existing positions closed: 15

65% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 23

23% more funds holding

Funds holding: 91 → 112 (+21)

10% less call options, than puts

Call options by funds: $768K | Put options by funds: $855K

50% less capital invested

Capital invested by funds: $406M → $204M (-$202M)

Holders
112
Holders Change
+21
Holders Change %
+23.08%
% of All Funds
2.54%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
36
Increased
38
Reduced
23
Closed
15
Calls
$768K
Puts
$855K
Net Calls
-$87K
Net Calls Change
+$531K

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$12.3M
2
BlackRock
BlackRock
New York
+$10M
3
NI
Numeric Investors
Massachusetts
+$6.69M
4
Citadel Advisors
Citadel Advisors
Florida
+$5.11M
5
Renaissance Technologies
Renaissance Technologies
New York
+$3.5M

Top Sellers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$24.9M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$18.6M
3
State Street
State Street
Massachusetts
-$13.1M
4
Viking Global Investors
Viking Global Investors
Connecticut
-$12.6M
5
ACM
Atika Capital Management
New York
-$3.69M
Name Holding Trade Value Shares
Change 		Change in
Stake
OAM
26
Oxford Asset Management
United Kingdom
$1.19M +$1.83M +7,149 New
Bank of New York Mellon
27
Bank of New York Mellon
New York
$1.11M +$290K +1,134 +21%
PAM
28
Panagora Asset Management
Massachusetts
$1.01M -$803K -3,136 -34%
CS
29
Candriam SCA
Luxembourg
$1M -$1.28M -5,000 -45%
Charles Schwab
30
Charles Schwab
California
$938K +$520K +2,032 +57%
LCM
31
Landscape Capital Management
New Jersey
$869K +$1.33M +5,202 New
AG
32
Artal Group
Luxembourg
$835K -$960K -3,750 -43%
Victory Capital Management
33
Victory Capital Management
Texas
$749K -$96.8K -378 -8%
Allianz Asset Management
34
Allianz Asset Management
Germany
$665K +$1.02M +3,981 New
Jennison Associates
35
Jennison Associates
New York
$651K +$997K +3,895 New
Squarepoint
36
Squarepoint
New York
$608K +$932K +3,638 New
Morgan Stanley
37
Morgan Stanley
New York
$598K +$144K +564 +19%
Wells Fargo
38
Wells Fargo
California
$519K +$363K +1,417 +84%
CAM
39
ClariVest Asset Management
California
$487K +$111K +435 +18%
FSA
40
Franklin Street Advisors
North Carolina
$464K +$256K +1,000 +56%
USAA
41
United Services Automobile Association
Texas
$421K +$20.5K +80 +3%
T. Rowe Price Associates
42
T. Rowe Price Associates
Maryland
$406K +$622K +2,429 New
California State Teachers Retirement System (CalSTRS)
43
California State Teachers Retirement System (CalSTRS)
California
$403K -$9.22K -36 -1%
TI
44
Trexquant Investment
Connecticut
$400K +$477K +1,864 +349%
BCM
45
Bridgeway Capital Management
Texas
$397K -$262K -1,023 -30%
Balyasny Asset Management
46
Balyasny Asset Management
Illinois
$394K +$428K +1,670 +242%
Swiss National Bank
47
Swiss National Bank
Switzerland
$378K +$580K +2,265 New
AIMCA
48
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$370K +$567K +2,215 New
Barclays
49
Barclays
United Kingdom
$352K +$232K +907 +76%
VEA
50
Virtus ETF Advisers
New York
$348K +$235K +917 +79%
1
2
3 4 5

CALA Hedge Fund Activity: Q4 2017 in Review

112 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Calithera Biosciences, Inc (CALA) for Q4 2017, worth a combined $204M — down 50% from $406M a quarter earlier.

Buyers outnumbered sellers: 36 funds opened new CALA positions and 15 closed out — a net gain of 21 holders — while 38 added to existing stakes and 23 trimmed.

The largest buyer was Millennium Management, adding an estimated $12.3M. The largest seller was Adage Capital Partners, cutting an estimated $24.9M.

  • 112 institutional investors held Calithera Biosciences, Inc (CALA) as of Q4 2017, up from 91 in Q3 2017.
  • Funds reported $204M of Calithera Biosciences, Inc stock for Q4 2017, down 50% quarter-over-quarter.
  • 36 funds opened new Calithera Biosciences, Inc positions in Q4 2017 and 15 closed out, a net change of +21 holders.
  • The largest Calithera Biosciences, Inc buyer in Q4 2017 was Millennium Management, an estimated $12.3M added.
  • The largest Calithera Biosciences, Inc seller in Q4 2017 was Adage Capital Partners, an estimated $24.9M sold.

Based on aggregated 13F filings for Q4 2017.